Advisory Board and Editors Cardiology
Helder Nakaya
Prof. Helder Nakaya is Deputy Director of School of Pharmaceutical Sciences at University of São Paulo, Brazil, Associate Professor at University of São Paulo, Brazil, and Adjunct Professor of the School of Medicine, Emory University, USA. He has a PhD in Molecular Biology with extensive training in Bioinformatics. He is an expert in Systems Vaccinology, an interdisciplinary field that combines systems-wide measurements, networks, and predictive modelling in the context of vaccines and infectious disease. Dr. Nakaya has developed systems biology approaches to understand and predict the mechanisms of vaccine induced-immunity for Yellow Fever, seasonal Influenza, Meningococcal, and Tularemia vaccines. His lab is focused on investigating the basis of infectious diseases using computational systems biology.
Giribabu Nelli
Dr. Giribabu Nelli is a Senior Lecturer within the Department of Physiology at Universiti Malaya.
Hi primary research areas include, Reproductive Biology, Diabetes and their complications, and Natural Products Research.
Ghanshyam Palamaner Subash Shantha
Dr. Ghanshyam Palamaner Subash Shantha is an academic cardiac electrophysiologist and faculty physician at Wake Forest University. His clinical interests include atrial fibrillation, leadless pacemakers and ventricular tachycardia management, and his research interests include epidemiology and prevention of diseases.
Gustavo R Pedrino
Dr. Gustavo Pedrino is currently, an Associate Professor in the Department of Physiological Sciences at the Institute of Biological Sciences of the Federal University of Goiás (ICB/UFG), where he coordinates the Center for Research in Neuroscience and Cardiovascular Physiology.
His research focuses on the influence of central inflammatory processes on neuronal and sympathetic hyperactivity in cardiovascular diseases such as hypertension and heart failure; neural pathways and mechanisms involved in the cardiovascular improvement observed with physical training; polymorphisms of ACE and ACE II enzymes and susceptibility to the development of cardiovascular diseases; synthesis of prototypes for drugs that act on the cardiovascular system; metabolic programming during pregnancy, lactation, and puberty; and physiopharmacology of natural and synthetic products.
Dr. Pedrino graduated in Biological Sciences (Medical Modality) from the Federal University of São Paulo (UNIFESP). He obtained the titles of Master and Doctor in Science from the Graduate Program in Pharmacology at UNIFESP. During the doctorate, he spent one year as a Research Fellow at the Department of Physiology of The University of Texas Health Science Center at San Antonio and completed postdoctoral studies at UNIFESP.
He served as the Coordinator of the Multicenter Graduate Program in Physiological Sciences (2012-2013) and the Undergraduate Course in Biomedicine at ICB/UFG (2014-2018). Acted as Secretary (2017-2018) of the Deliberative Council and Treasurer (2019-2020) of the Brazilian Society of Physiology (SBFis).
Currently, he is the Director of ICB/UFG (2018-2022/2022-2026), President of the Deliberative Council of SBFis, and Treasurer of the Federation of Experimental Biology Societies (FeSBE 2022-2023/2024-2025). Recognized as a Productivity Research Fellow 1C by the Committee on Biophysics, Pharmacology, Physiology, and Neurosciences of CNPq (2020-2024).
Yonghong Peng
Dr. Peng is a Professor of Data Science at the University of Sunderland. He is a Principal Investigator in Bioinformatics and Systems Biology and Medicine, and Principal Data Scientist working on Big Data Integration, Data Mining and Computational Intelligence. Dr. Peng's Data Science and BioMedical informatics (DS & BMI) research group focuses on development of innovative data analytics approaches to enable systematical analysis of biological data, medical images, and healthcare data and to gain new knowledge and insights from the integrative analytics of diverse data sources.
Prashanth Ravishankar
Dr. Prashanth Ravishankar received his PhD in Biomedical Engineering from the University of Arkansas. He is a Research and Development Scientist at Namida Lab Inc.
He has over a decade of experience in areas of Bioengineering, Biomaterials, Mechanobiology, Tissue Engineering, and Bone and Cardiovascular Bioengineering. He has presented at international conferences in the USA, Canada, and Abu Dhabi. He also serves as an editorial member on BMC Research Notes and as a reviewer for journals and conferences.
Fatima Saqib
Dr. Fatima Saqib, has a PhD in Pharmacology from Bahauddin Zakariya University. Currently, she is serving as Professor (Assistant) in BZU, Multan. Previously she served as Lecturer for 8 years. She has supervised 34 M.Phil students and 5 PhD students under supervision. She has published 38 international research articles and review paper with a total IF120 with h-index 12, i-index 16 and total google scholar citations 437.
Ripon Sarkar
Ripon Sarkar is a dedicated researcher with over a decade of experience in cutting-edge technology in the fields of mitochondrial metabolism, cardiovascular disease, cancer biology and tissue engineering. Dr. Sarkar has demonstrated a profound commitment to advancing scientific knowledge and innovation.
Currently serving as a Postdoctoral Research Fellow at The UTHealth at Houston, Dr. Sarkar's research focuses on cardiovascular disease, especially on aortic and coronary artery disease to understand the molecular mechanism. His proficiency in these areas has been instrumental in conducting groundbreaking research and publishing his findings in reputable scientific journals. Throughout his academic and professional journey, Dr. Sarkar has been recognized with numerous honors and awards.
Dr. Sarkar's dedication to advancing scientific knowledge is further evidenced by his service to the community and his editorial contributions to various scientific journals. He is committed to leveraging his expertise to address pressing healthcare challenges and make meaningful contributions to society.
Teresa M Seccia
Associate Professor in Internal Medicine, Dept. Medicine, University of Padova, Italy.
International PhD Degree in 'Arterial Hypertension and Vascular Biology'.
Field of interest: Clinical and translational research in high blood pressure and cardiovascular diseases.
Consolato Sergi
Dr. Consolato M. Sergi is Chief of Anatomical Pathology of the Children's Hospital of Eastern Ontario, University of Ottawa, Ontario, Canada and Emeritus Professor of Pathology and Pediatrics of the University of Alberta, Canada. Dr. Sergi was born in Rome (Italy), obtained his MD degree with honors at the University of Genoa, Italy, his Human Pathology degree at the University of Heidelberg, Germany, the title of the hon. Clinical Reader of the University of Bristol, UK, his Ph.D./Habilitation at the University of Innsbruck, Austria, his MSc Public Health in Austria, and his FRCPC degree at the Royal College in Ottawa. Dr. Sergi’s specialty areas of interest are congenital heart disease and metabolic diseases, obstructive cholangiopathies, carcinogenesis (bone/soft tissue/liver), gut microbiome, and mitochondrial DNA related cardiomyopathies.
Huashan Shi
Professor Shi Huashan is an Associate Professor at Sichuan University. His expertise is in the molecular biology of tumours and tumour transcriptomics. He is currently engaged in clinical and basic translational research, including tumour microenvironment and novel immunotherapeutic modalities, and research on the mechanisms and medical applications related to tumour cell vaccines.
Edward R Smith
Professor Edward Smith is an Associate Professor in the Department of Medicine, University of Melbourne and Senior Scientist at the Kincaid-Smith Renal Laboratories, Department of Nephrology, The Royal Melbourne Hospital. He is interested in mineral metabolism and kidney disease.